Prostate cancer in elderly men.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Reviews in urology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 18660852PMCID PMC2483315
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hormonal therapy of prostate cancer.

  2010cited by this paper
• Cancer Statistics, 2007

  2007cited by this paper
• The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397)

  2007cited by this paper
• The quality of life of men with locally advanced prostate cancer during neoadjuvant hormone therapy: data from the Medical Research Council RT01 trial (ISRCTN 47772397)

  2007cited by this paper
• Management of prostate cancer. Part 2: localized and locally advanced disease

  2006cited by this paper
• Endocrine complications of androgen-deprivation therapy in men with prostate cancer.

  2006cited by this paper
• Active surveillance versus radical treatment for favorable-risk localized prostate cancer

  2006cited by this paper
• Intermittent hormone therapy in nonmetastatic prostate cancer.

  2006cited by this paper
• Identifying men diagnosed with clinically localized prostate cancer who are at high risk for death from prostate cancer.

  2006cited by this paper
• Intermittent androgen deprivation: clinical experience and practical applications.

  2006cited by this paper
• Survival associated with treatment vs observation of localized prostate cancer in elderly men.

  2006cited by this paper
• New techniques and management options for localized prostate cancer.

  2006cited by this paper
• Radical prostatectomy for octogenarians: how old is too old?

  2006cited by this paper
• Bcl-2 Expression as a Predictive Marker of Hormone-Refractory Prostate Cancer Treated with Taxane-Based Chemotherapy

  2006cited by this paper
• Relapse after radical prostatectomy correlates with preoperative PSA velocity and tumor volume: results from a screening population.

  2006cited by this paper
• Active surveillance with selective delayed intervention for favorable risk prostate cancer: clinical experience and a 'number needed to treat' analysis.

  2006cited by this paper
• Do patients with localized prostate cancer treatment really want more aggressive treatment?

  2006cited by this paper
• Hormonal therapy for prostate cancer.

  2006cited by this paper
• Practice patterns in screening and management of prostate cancer in elderly men.

  2006cited by this paper
• 20-year outcomes following conservative management of clinically localized prostate cancer.

  2005cited by this paper
• Addressing the needs of the high-risk prostate cancer patient.

  2005cited by this paper
• Is there age bias in the treatment of localized prostate carcinoma?

  2004cited by this paper
• The Residue Determinant

  2004cited by this paper
• When to diagnose and how to treat prostate cancer in the "not too fit" elderly.

  2003cited by this paper
• Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE).

  2003cited by this paper
• Continued undertreatment of older men with localized prostate cancer.

  2003cited by this paper
• Epidemiology of prostate cancer.

  2003cited by this paper
• The Department of Defense center for prostate disease research.

  2002cited by this paper
• The ten-year rule revisited: accuracy of clinicians' estimates of life expectancy in patients with localized prostate cancer.

  2002cited by this paper
• An economic overview of prostate carcinoma

  2001cited by this paper
• Deaths: preliminary data for 2000.

  2001cited by this paper
• Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study.

  2001cited by this paper
• Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection.

  2000cited by this paper
• Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study.

  2000cited by this paper
• Mean time to cancer‐specific death of apparently clinically localized prostate cancer: policy implications for threshold ages in prostate‐specific antigen screening and ablative therapy

  2000cited by this paper
• Primary treatment choices for men with clinically localized prostate carcinoma detected by screening

  2000cited by this paper
• Prostate-specific antigen testing of older men.

  1999cited by this paper
• Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer.

  1999cited by this paper
• Effect of age and surgical approach on complications and short-term mortality after radical prostatectomy--a population-based study.

  1999cited by this paper
• Comorbidity in patients with prostate cancer and its relevance to treatment choice

  1999cited by this paper
• Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study.

  1998cited by this paper
• Early detection of prostate cancer.

  1998cited by this paper
• Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden.

  1997cited by this paper
• Temporal trends in rates of prostate cancer: declining incidence of advanced stage disease, 1974 to 1994.

  1997cited by this paper
• Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening.

  1996cited by this paper
• Factors that determine the treatment for local and regional prostate cancer.

  1996cited by this paper
• Recent trends in incidence and treatment of prostate cancer among elderly men.

  1995cited by this paper
• Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part IV: Estimating the risks and benefits of an early detection program.

  1995cited by this paper
• Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report.

  1995cited by this paper
• Should we treat localized prostate cancer? An opinion.

  1995cited by this paper
• Survival of men with clinically localized prostate cancer detected in the eighth decade of life.

  1994cited by this paper
• Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.

  1994cited by this paper
• Results of conservative management of clinically localized prostate cancer.

  1994cited by this paper
• Results of conservative management of clinically localized prostate cancer.

  1994cited by this paper
• Expectant management of early stage prostatic cancer: Swedish experience.

  1994cited by this paper
• A structured literature review of treatment for localized prostate cancer. Prostate Disease Patient Outcome Research Team.

  1993cited by this paper
• An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team.

  1993cited by this paper
• Determinants of cancer therapy in elderly patients

  1993cited by this paper
• Patterns of care related to age of men with prostate cancer

  1991cited by this paper
• Clinical evidence for and implications of the multistep development of prostate cancer.

  1990cited by this paper
• Early detection of prostate cancer.

  1989cited by this paper
• Cancer statistics

  1989cited by this paper
• Choice of cancer therapy varies with age of patient.

  1986cited by this paper
• Intermittent endocrine therapy for advanced prostate cancer

  1986cited by this paper

• Retrospective analysis of high-dose-rate brachytherapy for patients with prostate cancer aged ≥ 75 years

  2026cites this paper
• Burden of prostate cancer in older adults, 1990–2021: a systematic analysis based on the global burden of disease study 2021

  2026cites this paper
• Beyond Chronologic Age: Frailty, Geriatric Assessment, and Personalized Care for Older Adults With Genitourinary Cancer.

  2026cites this paper
• Evaluation of Loss of the Y Chromosome in Peripheral Blood as a Biomarker for Prostate Cancer.

  2026cites this paper
• Systemic Biologic Treatment for Psoriasis in Elderly Patients

  2025cites this paper
• Comparison of Oncological Outcomes of Conventional Androgen Deprivation Therapy (ADT) and ADT Plus Androgen Receptor Signaling Inhibitor in Older Patients With Metastatic Castration‐Sensitive Prostate Cancer

  2025cites this paper
• Anticancer Potential of Wogonin: A Comprehensive Treatise

  2025cites this paper
• Assessing the role of the microbiome in the pathogenesis of prostate cancer and its relationship with patient clinical characteristics

  2025cites this paper
• Mechanisms underlying prostate cancer sensitivity to reactive oxygen species: overcoming radiotherapy resistance and recent clinical advances

  2025cites this paper
• Global trends in prostate cancer burden among adults aged 80 years and older from 1990 to 2021 based on the global burden of disease 2021

  2025cites this paper
• Impact of Gleason, Stage and Age on Surgery and Radiotherapy in Prostate Cancer Patients in Northern Italy.

  2025cites this paper
• Does age affect functional and perioperative outcomes after robotic-assisted prostatectomy in localized prostate cancer?

  2025cites this paper
• Survival Outcomes for Men over 80 Years Undergoing Transrectal Ultrasound-Guided Prostate Biopsy: A Prospective Analysis

  2024cites this paper
• Functional interaction between receptor tyrosine kinase MET and ETS transcription factors promotes prostate cancer progression

  2024cites this paper
• Adaption and National Validation of a Tool for Predicting Mortality from Other Causes Among Men with Nonmetastatic Prostate Cancer.

  2024cites this paper
• Examining the trend of mortality of genitourinary system cancers in Babol, North Iran (2013–2021)

  2024influential citation
• Effect of Selol on Tumor Morphology and Biochemical Parameters Associated with Oxidative Stress in a Prostate Tumor-Bearing Mice Model

  2024cites this paper
• Outcomes in studies regarding older patients with prostate cancer: A systematic review.

  2024cites this paper
• Research progress on the role of lipoxygenase and its inhibitors in prostate cancer.

  2024cites this paper
• FastMRI Prostate: A Publicly Available, Biparametric MRI Dataset to Advance Machine Learning for Prostate Cancer Imaging

  2023cites this paper
• Clinical Outcomes of Enzalutamide in Metastatic Hormone-sensitive Prostate Cancer in Patients Aged <75 and ≥75 Years: ARCHES Post Hoc Analysis.

  2023cites this paper
• The Role of SOX Transcription Factors in Ageing and Age-Related Diseases

  2023cites this paper
• Cost-Effectiveness of Annual Prostate MRI and Potential MRI-Guided Biopsy After Prostate-Specific Antigen Test Results

  2023cites this paper
• Incidence and risk factors of prostate cancer among the Northern and Eastern parts of the United Arab Emirates population

  2023cites this paper
• Flavones: The Apoptosis in Prostate Cancer of Three Flavones Selected as Therapeutic Candidate Models

  2023cites this paper
• Dietary flavonoids as modulators of non-coding RNAs in hormone-associated cancer

  2023cites this paper
• Lived experiences of prostate cancer patients in an urban metropolis in North Central, Nigeria.

  2023cites this paper
• The levels and trends of cancer incidence in the elderly population at national and sub‐national scales in Iran from 1990 to 2016

  2023cites this paper
• The role of frailty in modifying physical function and quality of life over time in older men with metastatic castration-resistant prostate cancer.

  2023cites this paper
• The 15-year national trends of genital cancer incidence among Iranian men and women; 2005–2020

  2023cites this paper
• Prognostic factors for mental wellbeing in prostate cancer: A systematic review and meta‐analysis

  2023cites this paper
• Pre-Exposure to Stress-Inducing Agents Increase the Anticancer Efficacy of Focused Ultrasound against Aggressive Prostate Cancer Cells

  2022cites this paper
• Age- and Stage-Dependent Prostate Cancer Aggressiveness Associated with Differential Notch Signaling

  2022cites this paper
• Prostate biopsy and its outcome in a tertiary hospital in southern Nigeria

  2022cites this paper
• Understanding of PSA biology, factors affecting PSA detection, challenges, various biomarkers, methods, and future perspective of prostate cancer detection and diagnosis

  2022cites this paper
• Treatment Patterns and Overall Survival Outcomes Among Patients Aged 80 yr or Older with High-risk Prostate Cancer

  2022influential citation
• Variable Selection via Grace-AKO with Applications in Genomics

  2022cites this paper
• SBRT for Localized Prostate Cancer: CyberKnife vs. VMAT-FFF, a Dosimetric Study

  2022cites this paper
• TGF-β controls stromal telomere length through epigenetic modifications

  2022cites this paper
• Long-Term Medical Resource Consumption of Radical Prostatectomy vs. Intensity-Modulated Radiotherapy for Old Patients With Prostate Cancer: A Nationwide Population-Based Cohort Study

  2022influential citation
• The Latest Data Specifically Focused on Long-Term Oncologic Prognostication for Very Old Adults with Acute Vulnerable Localized Prostate Cancer: A Nationwide Cohort Study

  2022influential citation
• Using health insurance claims data to assess long‐term disease progression in a prostate cancer cohort

  2022cites this paper
• Prevalence of multimorbidity in men of African descent with and without prostate cancer in Soweto, South Africa

  2022cites this paper
• Prevalence of Risk Factors and Lifestyle Choices Associated with Increased Cancer in Participants from Trinidad and Tobago

  2022cites this paper
• Grace-AKO: a novel and stable knockoff filter for variable selection incorporating gene network structures

  2022cites this paper
• Genomic analyses identify key molecules and significant signaling pathways in AZIN1 regulated prostate cancer cells

  2022cites this paper
• Prostate Cancer Outcomes in Patients Living With HIV/AIDS Treated With Radiation Therapy: A Systematic Review

  2022cites this paper
• Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data

  2022cites this paper
• Differential expression of protein disulfide-isomerase A3 isoforms, PDIA3 and PDIA3N, in human prostate cancer cell lines representing different stages of prostate cancer

  2021cites this paper
• Is there a PSA cut-off value indicating incidental prostate cancer in patients undergoing surgery for benign prostatic hyperplasia?

  2021cites this paper
• Pathogenic BRCA Variants as Biomarkers for Risk in Prostate Cancer

  2021cites this paper
• Prosztatarákkal diagnosztizált betegek egészségmagatartásának vizsgálata.

  2021cites this paper
• Optimal treatment sequencing of abiraterone acetate plus prednisone and enzalutamide in patients with castration-resistant metastatic prostate cancer: A systematic review and meta-analysis.

  2021cites this paper
• Latest Comprehensive Medical Resource Consumption in Robot-Assisted versus Laparoscopic and Traditional Open Radical Prostatectomy: A Nationwide Population-Based Cohort Study

  2021cites this paper
• Association of race with receipt of definitive therapy for high risk prostate cancer in older men.

  2021cites this paper
• Prostate Cancer Screening Behaviors Based on the Health Belief Model in Men Aged 40-70 Years in Fasa City, Fars Province, Iran, in 2019

  2021cites this paper
• Characteristics of patients undergoing robotic-assisted prostatectomy. Observational study

  2021cites this paper
• Induction of apoptosis in human hormone‐refractory prostate cancer cell lines by using resveratrol in combination with AT‐101

  2021cites this paper
• SPATIAL ANALYSIS OF PROSTATE CANCER INCIDENCE IN IRAQ DURING 2000-2015

  2021cites this paper
• Comparison of Acute and Chronic Surgical Complications Following Robot-Assisted, Laparoscopic, and Traditional Open Radical Prostatectomy Among Men in Taiwan

  2021cites this paper
• Impact of Age on Patient-Reported Outcomes Following Stereotactic Body Radiation Therapy for Prostate Cancer

  2021cites this paper
• An integrative active surveillance of prostate cancer.

  2021cites this paper
• An Integrative Counseling Approach for African American Couples With Prostate Cancer

  2021cites this paper
• A Novel Controlled PTEN-Knockout Mouse Model for Prostate Cancer Study

  2021cites this paper
• Insights of Curcumin in Prostate Cancer with update: Review

  2020cites this paper
• Trends in Cancer Prevalence in Punjab, Pakistan: A Systematic Study from 2010 to 2016

  2020influential citation
• SYNTHESIS AND CHARACTERIZATION OF ENZYME CATALYZED BIODEGRADABLE â•œCLICK-ENEâ•š POLYMERS FOR TARGETED CANCER THERAPY

  2020cites this paper
• Does Physical Activity Regulate Prostate Carcinogenesis and Prostate Cancer Outcomes? A Narrative Review

  2020cites this paper
• Prostate cancer and human papillomavirus infection: a recent literature review

  2020cites this paper
• CD4+ T helper 17 cell response of aged mice promotes prostate cancer cell migration and invasion

  2020cites this paper
• Association study between common variations in some candidate genes and prostate adenocarcinoma predisposition through multi-stage approach in Iranian population

  2020cites this paper
• Hypogonadism and its treatment among prostate cancer survivors

  2020cites this paper
• Saturation transfer properties of tumour xenografts derived from prostate cancer cell lines 22Rv1 and DU145

  2020cites this paper
• Waiting times for prostate cancer: A review

  2020cites this paper
• A Weak and Semi-supervised Segmentation Method for Prostate Cancer in TRUS Images

  2020cites this paper
• Hybrid algorithm for the classification of prostate cancer patients of the MCC-Spain study based on support vector machines and genetic algorithms

  2020cites this paper
• Leptin Promotes Prostate Cancer Proliferation and Migration by Stimulating STAT3 Pathway

  2020cites this paper
• Targeting miRNAs by polyphenols: novel therapeutic strategy for aging.

  2020cites this paper
• Prostate cancer in Saudi Arabia: trends in incidence, morphological and epidemiological characteristics

  2020cites this paper
• Dosimetric comparison among cyberknife, helical tomotherapy and VMAT for hypofractionated treatment in localized prostate cancer

  2020cites this paper
• Autonomous Extraction of Gleason Patterns for Grading Prostate Cancer using Multi-Gigapixel Whole Slide Images

  2020cites this paper
• Consortum between mast cell and prostatic lesions-An etiological factor or mere coexistence

  2020cites this paper
• Variation-Aware Federated Learning With Multi-Source Decentralized Medical Image Data

  2020cites this paper
• Predicting new drug indications for prostate cancer: The integration of an in silico proteochemometric network pharmacology platform with patient‐derived primary prostate cells

  2020cites this paper
• Distinct cell-types in the prostate share an aging signature suggestive of metabolic reprogramming.

  2020cites this paper
• A Comprehensive Analysis of FUT8 Overexpressing Prostate Cancer Cells Reveals the Role of EGFR in Castration Resistance

  2020cites this paper
• Melatonin ameliorates degenerative alterations caused by age in the rat prostate and mitigates high‐fat diet damages

  2020cites this paper
• Cancer Prevention by Natural Products Introduced into the Diet—Selected Cyclitols

  2020cites this paper
• Value of MR-US fusion in guidance of repeated prostate biopsy in men with PSA < 10 ng/mL.

  2019cites this paper
• Experience with using fosfestrol for treating metastatic castrate-resistant prostate cancer in resource-limited setting

  2019cites this paper
• Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population‐based cohort study

  2019cites this paper
• Conditional random fields improve the CNN-based prostate cancer classification performance

  2019cites this paper
• Identification of a novel Protein Disulfide-isomerase A3 (PDIA3) transcript variant as a potential biomarker associated with late stage prostate cancer

  2019cites this paper
• Novel molecular targets in advanced prostate cancer

  2019cites this paper
• Targeting Epigenetic Regulators in Cancer to Overcome Resistance to Targeted Therapy

  2019cites this paper
• Cytotoxic effect of N-acetyl cysteine in DU145 human prostate cancer cells

  2019cites this paper
• Polygenic hazard score is associated with prostate cancer in multi-ethnic populations

  2019cites this paper
• Radiotherapy with or without androgen deprivation therapy in intermediate risk prostate cancer?

  2019cites this paper
• Prospective evaluation of urinary steroids and prostate carcinoma-induced deviation: preliminary results.

  2019cites this paper
• Dosimetric Comparison: Intensity Modulated Radiation Therapy Vs. 3D Conformal Radiotherapy in Prostate Cancer Radical Treatment

  2019cites this paper